PRVA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
PRVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Privia Health Group's Enterprise Value is $2,571 Mil. Privia Health Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was $17 Mil. Therefore, Privia Health Group's EV-to-EBIT ratio for today is 151.39.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Privia Health Group's Enterprise Value is $2,571 Mil. Privia Health Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was $24 Mil. Therefore, Privia Health Group's EV-to-EBITDA ratio for today is 106.02.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Privia Health Group's Enterprise Value is $2,571 Mil. Privia Health Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was $1,736 Mil. Therefore, Privia Health Group's EV-to-Revenue ratio for today is 1.48.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Privia Health Group's Enterprise Value is $2,571 Mil. Privia Health Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was $109 Mil. Therefore, Privia Health Group's EV-to-FCF ratio for today is 23.53.
The historical data trend for Privia Health Group's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Privia Health Group Annual Data | ||||||||||||||||
Trend | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||
Enterprise Value | Get a 7-Day Free Trial | - | 2,539.00 | 2,288.10 | 2,387.27 | 1,914.75 |
Privia Health Group Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Enterprise Value | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
2,387.27 | 2,027.32 | 1,744.15 | 1,815.82 | 1,914.75 |
For the Health Information Services subindustry, Privia Health Group's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Privia Health Group's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Privia Health Group's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Privia Health Group's Enterprise Value for the fiscal year that ended in Dec. 2024 is calculated as
Enterprise Value (A: Dec. 2024 ) | |||||
= | Market Cap | + | Preferred Stock | + | Long-Term Debt & Capital Lease Obligation |
= | 2352.04095 | + | 0 | + | 3.037 |
+ | Short-Term Debt & Capital Lease Obligation | + | Minority Interest | - | Cash, Cash Equivalents, Marketable Securities |
+ | 2.553 | + | 48.264 | - | 491.149 |
= | 1,915 |
Privia Health Group's Enterprise Value for the quarter that ended in Dec. 2024 is calculated as
Enterprise Value (Q: Dec. 2024 ) | |||||
= | Market Cap | + | Preferred Stock | + | Long-Term Debt & Capital Lease Obligation |
= | 2352.04095 | + | 0 | + | 3.037 |
+ | Short-Term Debt & Capital Lease Obligation | + | Minority Interest | - | Cash, Cash Equivalents, Marketable Securities |
+ | 2.553 | + | 48.264 | - | 491.149 |
= | 1,915 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Privia Health Group (NAS:PRVA) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Privia Health Group's EV-to-EBIT for today is
EV-to-EBIT | = | Enterprise Value (Today) | / | EBIT (TTM) |
= | 2570.951 | / | 16.982 | |
= | 151.39 |
Privia Health Group's current Enterprise Value is $2,571 Mil.
Privia Health Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $17 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Privia Health Group's EV-to-EBITDA for today is:
EV-to-EBITDA | = | Enterprise Value (Today) | / | EBITDA(TTM) |
= | 2570.951 | / | 24.25 | |
= | 106.02 |
Privia Health Group's current Enterprise Value is $2,571 Mil.
Privia Health Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $24 Mil.
3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.
Privia Health Group's EV-to-Revenue for today is:
EV-to-Revenue | = | Enterprise Value (Today) | / | Revenue (TTM) |
= | 2570.951 | / | 1736.39 | |
= | 1.48 |
Privia Health Group's current Enterprise Value is $2,571 Mil.
Privia Health Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,736 Mil.
4. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.
Privia Health Group's EV-to-FCF for today is:
EV-to-FCF | = | Enterprise Value (Today) | / | Free Cash Flow (TTM) |
= | 2570.951 | / | 109.282 | |
= | 23.53 |
Privia Health Group's current Enterprise Value is $2,571 Mil.
Privia Health Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $109 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Privia Health Group's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
David Mountcastle | officer: Chief Financial Officer | 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203 |
Parth Mehrotra | officer: President and COO | 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203 |
Adam Boehler | director | 1215 5TH AVE N,, NASHVILLE TN 37208 |
Thomas A Mccarthy | director | 1601 CHESTNUT STREET, SHAREHOLDER SERVICES TL18Y, PHILADELPHIA PA 19192 |
Thomas Bartrum | officer: EVP, General Counsel | 950 N. GLEBE RD., SUITE 700, ALEXANDRIA VA 22203 |
Matthew Shawn Morris | director, officer: Chief Executive Officer | 950 N. GLEBE ST., SUITE 700, ARLINGTON VA 22203 |
William M Sullivan | director | ONE PENN PLAZA, SUITE 5300, NY NY 10119 |
Pamela O Kimmet | director | 11207 ORANGE HIBISCUS LANE, PALM BEACH GARDENS FL 33418 |
David S Wichmann | director | BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752 |
Goldman Sachs Group Inc | 10 percent owner | 200 WEST STREET, NEW YORK NY 10282 |
Jeffrey Daniel Bernstein | director | 200 WEST STREET, NEW YORK NY 10282 |
Pamplona Capital Partners Iii, L.p. | 10 percent owner | 94 SOLARIS AVENUE, CAMANA BAY, P.O. BOX 1348, GRAND CAYMAN E9 KY1-1108 |
Mbd Advisors, L.l.c. | 10 percent owner | 200 WEST STREET, NEW YORK NY 10282 |
Jeffrey B Butler | director | 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22101 |
David P King | director | PRIVIA HEALTH GROUP, INC., 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203 |
From GuruFocus
By GuruFocus News • 11-08-2024
By GuruFocus News • 11-07-2024
By GuruFocus Research • 02-28-2024
By GuruFocus Research • 02-08-2024
By GuruFocus News • 10-09-2024
By GuruFocus News • 10-30-2024
By Marketwired • 06-25-2024
By Marketwired • 10-29-2024
By Marketwired • 01-24-2025
By GuruFocus News • 01-24-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.